Showing results (11-20 of 447) with videos related to
Sort By:
Pageof 45
International Journal of Clinical Oncology|December 24, 2004
Chemoradiotherapy for lung cancer: current status and perspectivesYuichiro OheThoracic Cancer|February 9, 2019
Mixed response to osimertinib and the beneficial effects of additional local therapyYuki Shinno, Yasushi Goto, Jun Sato, et al.Thoracic Cancer|February 15, 2019
Malignant pleural effusion as a predictor of the efficacy of anti-PD-1 antibody in patients with non-small cell lung cancerRyota Shibaki, Shuji Murakami, Yuki Shinno, et al.Thoracic Cancer|June 5, 2025
Successful Treatment of HER2 V659E Mutation-Positive Lung Adenocarcinoma With Trastuzumab Deruxtecan: A Case ReportMariko Nishihara, Yuki Shinno, Yoshihiro Masui, et al.JTO Clinical and Research Reports|November 24, 2025
Genetic Characteristics of Disease Flare After Lenvatinib Discontinuation in Patients With Thymic Carcinoma: A Brief ReportTomoaki Nakamura, Tatsuya Yoshida, Ken Masuda, et al.Respiratory Investigation|December 2, 2022
Prognostic role of modified Glasgow Prognostic score in elderly non-small cell lung cancer patients treated with anti-PD-1 antibodiesTomohiro Tanaka, Tatsuya Yoshida, Ken Masuda, et al.Clinical Lung Cancer|May 26, 2022
Efficacy of Immune Checkpoint Inhibitors in SMARCA4-Deficient Thoracic TumorYuki Shinno, Akihiko Yoshida, Ken Masuda, et al.Anticancer Research|December 3, 2024
Key Therapeutic Agents for Thymic Carcinoma in Real-world Clinical PracticeAkiko Tateishi, Yusuke Okuma, Yasushi Goto, et al.European Journal of Cancer (Oxford, England : 1990)|October 11, 2020
Impact of chemoradiotherapy on the immune-related tumour microenvironment and efficacy of anti-PD-(L)1 therapy for recurrences after chemoradiotherapy in patients with unresectable locally advanced non-small cell lung cancerMasayuki Shirasawa, Tatsuya Yoshida, Yuji Matsumoto, et al.Pageof 45